Vulva Cancer

The EORTC vulva cancer module is developed as a disease- and treatment specific questionnaire module for vulva cancer patients to supplement the EORTC QLQ-C30. The aim of the study is to test the scale structure, reliability, and validity of the EORTC VU34 in patients diagnosed with vulva cancer at different stages of disease and with different treatment modalities.We aim to develop a questionnaire module that allow broad international cross-cultural and cross-country adaptation which can be used in clinical trials.

The three first phases of development and validation is completed.

The questionnaire is now undergoing formal field testing with psychometric analyses.

Phase 4, currently recruiting.

The phase 3 paper needs more editing and acceptance by collaborators and EC in the EORTC:

Still working on recruiting more centers to speed up the recruitment rate.

Fast track update of newly entered data and patient inclusion.

The EORTC vulva cancer module is a specific questionnaire for patients with vulva cancer. We aim to test the validity of the questionnaire for use in patients from different countries, at different disease stages and in patients  undergoing different treatments. This will allow us to use the disease-specific questionnaire in the clinic and in future studies.